EDETEK Launches Sponsor Partnership Program to Support FDA Real Time Clinical Trials

EDETEK has launched a sponsor partnership program to assist life sciences companies in preparing for and participating in the U.S. Food and Drug Administration (FDA)'s Real Time Clinical Trials initiative, announced in a press release. The program supports the FDA's AI enabled optimization pilot for early phase clinical trials by leveraging EDETEK's AI based R&D Cloud platform.

The R&D Cloud enables continuous data visibility for clinical trial sponsors, allowing ongoing regulatory engagement, faster analysis, and improved patient safety monitoring. Built on a metadata driven, event based architecture, the platform delivers validated safety and efficacy signals in real time. It consolidates data collection, standardization, and governance, replacing fragmented batch workflows with a connected research environment.

EDETEK's system incorporates AI capabilities through its BioStat.AI and Ensemble AI Managed Services for risk detection, anomaly monitoring, and audit trail management. Regulatory dashboards provide insights into key risk indicators and quality tolerance limits to help maintain oversight throughout studies. The platform operates with GxP compliance and includes ISO 27001, 27701, 27017, and 42001 certifications.

Under the program, sponsors maintain full control over clinical strategy and interactions with the FDA, while EDETEK supplies technology and operational support for real time data reporting. The partnership model and R&D Cloud are now available to global clinical trial sponsors, biotechnology companies, and contract research organizations working in early phase clinical development.